The live attenuated varicella vaccine is a crucial vaccine that must be administered to children. This vaccine stimulates the immune system to produce immunity against the varicella-zoster virus, thereby effectively preventing varicella. By incorporating weakened varicella-zoster virus strains in the vaccine, it primes the body's defense mechanisms to recognize and fight off the actual virus.

A significant breakthrough in the field of varicella prevention has been achieved through the develop ment of the live attenuated varicella vaccine by BCHT. It stands as the world's first approved long-term (36 months) varicella vaccine. This vaccine has shown exceptional stability and an exceptionally high safety profile, making it a leading product in terms of quality within the domestic market